Supplementary Table 1 from Pharmacological Landscape of FDA-Approved Anticancer Drugs Reveals Sensitivities to Ixabepilone, Romidepsin, Omacetaxine, and Carfilzomib in Aggressive Meningiomas

Supplementary Table 1 from Pharmacological Landscape of FDA-Approved Anticancer Drugs Reveals Sensitivities to Ixabepilone, Romidepsin, Omacetaxine, and Carfilzomib in Aggressive Meningiomas

<p>Drug Screening Data</p>

Shranjeno v:
Bibliografske podrobnosti
Glavni avtor: Gerhard Jungwirth (15047922) (author)
Drugi avtorji: Tao Yu (15047925) (author), Fang Liu (15047928) (author), Junguo Cao (15047931) (author), Montadar Alaa Eddine (15047934) (author), Mahmoud Moustafa (15047937) (author), Amir Abdollahi (15026702) (author), Rolf Warta (15047940) (author), Andreas Unterberg (15047943) (author), Christel Herold-Mende (15047946) (author)
Izdano: 2025
Teme:
Cancer
Therapeutic Research and Development
CNS Cancers
Small Molecule Agents
Translational Research
Oznake: Označite
Brez oznak, prvi označite!
Komentirajte kot prvi!
Najprej se morate prijaviti

Podobne knjige/članki